Nickerson P - Search Results

1

Cytokines and the Th1/Th2 paradigm in transplantation.

Nickerson P, Steurer W, Steiger J, Zheng X, Steele AW, Strom TB. Nickerson P, et al. Curr Opin Immunol. 1994 Oct;6(5):757-64. doi: 10.1016/0952-7915(94)90081-7. Curr Opin Immunol. 1994. PMID: 7826531 Review.

2

Ex vivo coating of islet cell allografts with murine CTLA4/Fc promotes graft tolerance.

Steurer W, Nickerson PW, Steele AW, Steiger J, Zheng XX, Strom TB. Steurer W, et al. Among authors: nickerson pw. J Immunol. 1995 Aug 1;155(3):1165-74. J Immunol. 1995. PMID: 7543517

3

IL-2 knockout recipient mice reject islet cell allografts.

Steiger J, Nickerson PW, Steurer W, Moscovitch-Lopatin M, Strom TB. Steiger J, et al. Among authors: nickerson pw. J Immunol. 1995 Jul 1;155(1):489-98. J Immunol. 1995. PMID: 7602120

4

Administration of noncytolytic IL-10/Fc in murine models of lipopolysaccharide-induced septic shock and allogeneic islet transplantation.

Zheng XX, Steele AW, Nickerson PW, Steurer W, Steiger J, Strom TB. Zheng XX, et al. Among authors: nickerson pw. J Immunol. 1995 May 15;154(10):5590-600. J Immunol. 1995. PMID: 7730658

5

In pursuit of the "holy grail": allograft tolerance.

Nickerson PW, Steurer W, Steiger J, Strom TB. Nickerson PW, et al. Kidney Int Suppl. 1994 Jan;44:S40-9. Kidney Int Suppl. 1994. PMID: 8127033 Review. No abstract available.

6

Unmodified pancreatic islet allograft rejection results in the preferential expression of certain T cell activation transcripts.

O'Connell PJ, Pacheco-Silva A, Nickerson PW, Muggia RA, Bastos M, Kelley VR, Strom TB. O'Connell PJ, et al. Among authors: nickerson pw. J Immunol. 1993 Feb 1;150(3):1093-104. J Immunol. 1993. PMID: 8423334

7

Analysis of cytokine transcripts in pancreatic islet cell allografts during rejection and tolerance induction.

Nickerson P, Pacheco-Silva A, O'Connell PJ, Steurer W, Kelley VR, Strom TB. Nickerson P, et al. Transplant Proc. 1993 Feb;25(1 Pt 2):984-5. Transplant Proc. 1993. PMID: 8442291 No abstract available.

8

Irradiated B7-1 transduced primary acute myelogenous leukemia (AML) cells can be used as therapeutic vaccines in murine AML.

Dunussi-Joannopoulos K, Weinstein HJ, Nickerson PW, Strom TB, Burakoff SJ, Croop JM, Arceci RJ. Dunussi-Joannopoulos K, et al. Among authors: nickerson pw. Blood. 1996 Apr 1;87(7):2938-46. Blood. 1996. PMID: 8639914 Free article.

9

Prolonged islet allograft acceptance in the absence of interleukin 4 expression.

Nickerson P, Zheng XX, Steiger J, Steele AW, Steurer W, Roy-Chaudhury P, Müller W, Strom TB. Nickerson P, et al. Transpl Immunol. 1996 Mar;4(1):81-5. doi: 10.1016/s0966-3274(96)80043-8. Transpl Immunol. 1996. PMID: 8762019

10

The Th1/Th2 paradigm and the allograft response.

Strom TB, Roy-Chaudhury P, Manfro R, Zheng XX, Nickerson PW, Wood K, Bushell A. Strom TB, et al. Among authors: nickerson pw. Curr Opin Immunol. 1996 Oct;8(5):688-93. doi: 10.1016/s0952-7915(96)80087-2. Curr Opin Immunol. 1996. PMID: 8902395 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

367 results

Search Page

Filters